Hubungan Antara Asam Urat Dan Hba1c Pada Pasien Diabetes Mellitus Tipe 2
33
DAFTAR PUSTAKA
1. American Diabetes Association. Diagnosis and classification of diabetes
mellitus. Diabetes Care. 2013;36:67-74.
2. PERKENI (2011). Konsensus Pengelolaan dan pencegahan Diabetes Mellitus
tipe 2 di Indonesia. Jakarta. PB PERKENI.
3. Herman JB, Goldbourt U. Uric acid and diabetes: observations in a population
study. Lancet. 1982;2:240–3.
4. LV Qin, Meng XF, He FF, Chen S, Su H, Xiong J, et al. High seum uric acid
and increased risk of type 2 diabetes: A systemic review and meta-analysis of
prospective cohort studies. PLOS one. 2013;8(2):e56-64.
5. Kramer CK, Muhlen DV, Jassal SK, Connor EB. Serum uric acid levels improve
prediction of incident type 2 diabetes in individuals with impaired fasting
glucose: The Rancho Bernardo Study. Diabetes Care. 2009;32:1272-3.
6. Lee J, Sparrow D, Vokonas PS, Landsberg L & Weiss ST. Uric acid and
coronary heart disease rik: Evidence of a role uric acid in the obesity-insulin
resistance. Am J Epidemiol. 1995;142(3):288-94.
7. Krishnan E, Pandya BJ, Chung L, Hariri A, Dabbous O. Hyperuricemia in
young adults and risk of insulin resistance, prediabetes and diabetes, A 15-years
follow-up study. Am J Epidemiol. 2012;176(2):108-16.
8. Oda E, Kawai R, Sukumaran V, Watanabe K. Uric acid is positively associated
with metabolic syndrome but negatively associated with diabetes in Japanese
man. Inter MedJ.2009;48:1785-91.
9. Ogbera AO & Azenabor AO. Hyperuricaemia and the metabolic syndrome in
Type 2 DM. Diabetology & Metabolic Syndrome. 2010;2:24-8.
10. Causevic A, Semiz S, Dzankovic AM, Cico B, Dujic T, Malenica M, et al.
Relevance of uric acid in progression of type 2 diabetes mellitus. Bosnian
Journal of Basic Medical Sciences.2010;10(1):54-9.
11. Nakagawa T, Cirillo P, Sato W, Gersch M, Sautin Y, RoncalC et al. The
conundrum of hyperuricemia, metabolicsyndrome, and renal disease. Intern
Emerg Med. 2008;3:313-8.
Universitas Sumatera Utara
34
12. Facchini F, Chen YD, Hollenbeck CB, Reaven GM. Relationship between
resistanceto insulin-mediated glucose uptake, urinary uric acid clearance, and
plasma uric acidconcentration. J Am Med Assoc. 1991;266:3008–11.
13. Choi HK, De Vera MA & Krisnan E. Gout and the risk of type 2 diabetes among
men with a high cardiovascular risk profile. Rheumatology. 2008;47:1567-70.
14. Kaur A, Kukreja S, Malhotra N & Neha. Serum adenosine deaminase activity
and its correlation with glycated haemoglobin levels in patients of type 2
diabetes mellitus. Journal of Clinical and Diagnostic Research. 2012;6(2):2526.
15. Gill A, Kukreja S, Malhotra N & Chhabra N. Correlation of the serum insulin
and the serum uric acid levels with the glycated haemoglobin levels in the
patients of type 2 diabetes mellitus. Journal of Clinical and Diagnostic
Research. 2013;7(7):1295-7.
16. Markkola HV & Jarvinen HY. Hyperuricemia and insulin resistance. J Clin
Endicrinol Metab.1994;78:25-29.
17. Meera KS, Vasudha KC & Sushmitha J. The study of serum uric acid levels in
non dependent diabetes meliitus (NIDDM). Asian J Pharm Biol Res.
2011;1(3):260-6.
18. Choi HK, Ford ES. Haemoglobin A1c, fasting glucose, serum C-peptide and
insulin resistance in relation to serum uric acid levels--the Third National Health
and Nutrition Examination Survey. Rheumatology (Oxford).2008; 47:713–7.
19. Rodriguez LAG, Soriano LC, Bpharm & Choi HK. Impact of diabetes against
the future risk of developing gout. Ann Rheum Dis. 2010;69(12):2090-4.
20. Cook DG, Shaper AG, Thelle DS, Whitehead TP. Serum uric acid, serum
glucose and diabetes:relationships in a population study. Postgrad Med J . 1986;
62:1001–6.
21. Safi AJ, Mehmood R, Khan MA & Haq AU. Association of serum uric acid with
type 2 diabetes mellitus. Journal of Post Graduate Medical Institute.
2004;18(1):59-63.
22. Nan H, Pang Z, Wang S, Gao W, Zhang L, Ren J, et al. Serum uric acid, plasma
glucose and diabetes. Diabetes & Vasc Dis Res. 2010;7(1):40-6.
Universitas Sumatera Utara
35
23. Lehto S, Niskanen L, Ronnemaa T & Laakso M. Serum uric acid is a strong
predictor of stroke in patients with non-insulin-dependent diabetes mellitus.
Stroke.1998;29:635-9.
24. Heinemann L & Richter B. Clinical Pharmacology of Human Insulin. Diabetes
Care. 1993;16(3):90-100.
25. Berry CE & JM Hare. Xanthine Oxidoreductase and Cardiovascular Disease:
Molecular
Mechanism
and
Pathophysiological
Implications.
Am
JPhysiol.2004;2:589-606.
26. Dincer HE, Dincer AP, Levinson DJ. Asymptomatic Hyperuricemia: ToTreat or
Not To Treat. Cleveland Clinic Journal of Medicine. 2002;3:594-606.
27. Zhao Y, Yang X, Lu W, Liao H & Liao F. Uricase Based Methods for in
Determination of Uric Acid in Serum.Microcim Acta. 2009;164:1-6.
28. Hediger MA, Johnson RJ, Miyazaki H & Endou H. Molecular Physiology of
Urate Transport. Am J Physiol. 2005:12:125-33.
29. Heinig M and RJ Johnson. Role of Uric Acid in Hypertension, RenalDisease,
and Metabolic Syndrome. Cleveland Clinic Journal of Medicine. 2006:11:105964.
30. Wang J, Chen RP, Lei L, Song QQ, Zhang RY, Li YB, et al. Prevalence and
determinants of hyperuricemia in type 2 diabetes mellitus patients with central
obesity in Guangdong Province in China. Asia Pac J Clin Nutr. 2013;22(4):5908.
31. Putra TR. Hiperurisemia. In: Sudoyo dkk (ed). Buku Ajar IlmuPeyakit Dalam
Jilid III Edisi V. Jakarta: FKUI, pp: 2550-5.
32. Cirillo P, Sato W, Reungjui S, Heinig M, Gersch M, Sautin Y, et al. Uric Acid,
the metabolic syndrome and renal disease. J Am Soc Nephrol. 2006;17:165-8.
33. Cohen E, Krause I, Fraser A, Goldberg E & Garty M. Hyperuricemia and
metabolic
syndrome:
Lesson
from
a
large
cohort
from
Israel.
IMAJ.2012;14:676-80.
34. Dehghan A, Hoek MV, Sijbrands EJG, Hofman A & Witteman JCM. High seum
uric acid as a novel risk factor for type 2 diabetes. Diabetes Care.
2008;31(2):361-2.
Universitas Sumatera Utara
36
35. Johnson RJ, Kang DH, Feig DI, Kivlighn S, Kanelis J, Watanabe S, et al. Is
There a Pathogenic Rule of Uric Acid in Hypertension, Cardiovascular and
Renal Disease? Hypertension Journal. 2003:22(3):1183-90.
36. Stefan AD, Wolfram D, Mathias R, Rakesh S, Francis F, Christoph K, et al. Uric
Acid and Survival in Chronic Heart Failure: Validation and Application in
Metabolic, Functional, and Hemodynamic Staging. Circulation.2003;107:19917.
37. Zanardo RC, Cruz JW, Martinez LL, de Oliveira MA, Fortes ZB. Probucol
restores the defective leukocyte-endothelial interaction in experimental diabetes .
Eur J Pharmacol. 2003;478:211–9.
38. Sannomiya P, Pereira MA, Garcia-Leme J. Inhibition of leukocyte chemotaxis
by serum factor in diabetes mellitus: selective depression of cell responses
mediated by complement-derived chemoattractants. Agents Actions. 1990;
30:369–76.
39. Niskanen L, Laaksonen DE, Lindstrom J, Eriksson JG, Keinanen-Kiukaanniemi
S, Ilanne-Parikka P, et al. Serum uric acid as a harbinger of metabolic outcome
in subjects with impaired glucose tolerance: the Finnish Diabetes Prevention
Study. Diabetes Care. 2006;29:709–11.
40. Kodama S, Saito K, Yachi Y, Asumi M, Sugawara A, et al. Association between
serum uric acid and development of type 2 diabetes. Diabetes Care. 2009;32:
1737–42.
41. So A, Thorens B. Uric acid transport and disease. J Clin Invest.
2010;120(6):1791–9.
42. DeFronzo RA, Cooke CR, Andres R, et al. The effect of insulin on renal
handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest.
1975;55(4):845–55.
43. Ter Maaten JC, Voorburg A, Heine RJ, et al. Renal handling of urate and
sodium during acute physiological hyperinsulinaemia in healthy subjects. Clin
Sci (Lond). 1997;92(1):51–8.
44. Tang L, Kubota M, Nagai A, Mamemoto K, Tokuda M. Hyperuricemia in obese
children and adolescents: the relationship with metabolic syndrome. Japan
Pediatric Reports. 2010;11(2):e12-16.
Universitas Sumatera Utara
37
45. Li-ying C, Wen-hua Z, Zhou-wen C, Hong-lei D, Jing-jing R, Jian-hua C, et al.
Relationship between hyperuricemia and metabolic syndrome. Zhejiang Univ
Sci B. 2007;8(8):593-8.
46. Lia C, Hsiehb M C, Changc S J. Metabolic syndrome, diabetes, and
hyperuricemia. Curr Opin Rheumatol. 2013;25:210–6.
47. Chen J H, Pan W H, Hsu C C, Yeh W T, Chuang S Y, Chen P Y, et al. Impact of
Obesity and Hypertriglyceridemia on Gout Development With or Without
Hyperuricemia: A Prospective Study. Arthritis Care Res. 2013;65(1):133–40.
48. Carlioglu A, Karakurt F, Maral S, Kasapoglu B, Darcin T. Serum Uric Acid
Levels in Obese Women. The New Journal of Medicine. 2011;28:34-7.
49. Kim S Y, Guevara J P, Kim K M, Choi H K, Heitjan D F, Albert D A.
Hyperuricemia and Coronary Heart Disease: A Systematic Review and MetaAnalysis. Arthritis Care Res. 2010;62(2):170–80.
50. Ito H, Abe M, Mifune M, Oshikiri K, Antoku S, Takeuchi Y, et al.
Hyperuricemia Is Independently Associated with Coronary Heart Disease and
Renal Dysfunction in patients with Type 2 Diabetes MellitusTogane. Plos One.
2011;6(11):e27817-24.
51. Perticone F, Sciacqua A, Perticone M, Arturi P, Scarpino P E, Quero M, et al.
Serum Uric Acid and 1-h Postload Glucose in Essential Hypertension. Diabetes
Care.2012;35:153–7.
52. Yılmaz M B, Erdem A, Yontar O C, Sarıkaya S, Yılmaz A, Madak N, et al.
Relationship between HbA1c and coronary flow rate in patients with type 2
diabetes mellitus and angiographically normal coronary arteries. Arch Turk Soc
Cardiol. 2010;38(6):405-10.
53. Puddu P, Puddu G M, Cravero E, Vizioli L, Muscari A. The relationships among
hyperuricemia, endothelial dysfunction, and cardiovascular diseases: Molecular
mechanisms and clinical implications. J of Cardiol. 2012;59:235-42.
54. Baldwin W, McRae S, Marek G, Wymer D, Pannu V, Baylis C, et al.
Hyperuricemia as a Mediator of the Proinflammatory Endocrine Imbalance in
the Adipose Tissue in a Murine Model of the Metabolic Syndrome. Diabetes.
2011;60:1258–69.
Universitas Sumatera Utara
38
55. Jellinger P S, Smith D A, Mehta A E, Ganda O, Handelsman Y, Rodbard H W,
et al. American association of clinical endocrinologists guidelines for
management of dyslipidemia and prevention of atherosclerosis. Endocrine
Practice. 2012;18(1):1-78.
Universitas Sumatera Utara
DAFTAR PUSTAKA
1. American Diabetes Association. Diagnosis and classification of diabetes
mellitus. Diabetes Care. 2013;36:67-74.
2. PERKENI (2011). Konsensus Pengelolaan dan pencegahan Diabetes Mellitus
tipe 2 di Indonesia. Jakarta. PB PERKENI.
3. Herman JB, Goldbourt U. Uric acid and diabetes: observations in a population
study. Lancet. 1982;2:240–3.
4. LV Qin, Meng XF, He FF, Chen S, Su H, Xiong J, et al. High seum uric acid
and increased risk of type 2 diabetes: A systemic review and meta-analysis of
prospective cohort studies. PLOS one. 2013;8(2):e56-64.
5. Kramer CK, Muhlen DV, Jassal SK, Connor EB. Serum uric acid levels improve
prediction of incident type 2 diabetes in individuals with impaired fasting
glucose: The Rancho Bernardo Study. Diabetes Care. 2009;32:1272-3.
6. Lee J, Sparrow D, Vokonas PS, Landsberg L & Weiss ST. Uric acid and
coronary heart disease rik: Evidence of a role uric acid in the obesity-insulin
resistance. Am J Epidemiol. 1995;142(3):288-94.
7. Krishnan E, Pandya BJ, Chung L, Hariri A, Dabbous O. Hyperuricemia in
young adults and risk of insulin resistance, prediabetes and diabetes, A 15-years
follow-up study. Am J Epidemiol. 2012;176(2):108-16.
8. Oda E, Kawai R, Sukumaran V, Watanabe K. Uric acid is positively associated
with metabolic syndrome but negatively associated with diabetes in Japanese
man. Inter MedJ.2009;48:1785-91.
9. Ogbera AO & Azenabor AO. Hyperuricaemia and the metabolic syndrome in
Type 2 DM. Diabetology & Metabolic Syndrome. 2010;2:24-8.
10. Causevic A, Semiz S, Dzankovic AM, Cico B, Dujic T, Malenica M, et al.
Relevance of uric acid in progression of type 2 diabetes mellitus. Bosnian
Journal of Basic Medical Sciences.2010;10(1):54-9.
11. Nakagawa T, Cirillo P, Sato W, Gersch M, Sautin Y, RoncalC et al. The
conundrum of hyperuricemia, metabolicsyndrome, and renal disease. Intern
Emerg Med. 2008;3:313-8.
Universitas Sumatera Utara
34
12. Facchini F, Chen YD, Hollenbeck CB, Reaven GM. Relationship between
resistanceto insulin-mediated glucose uptake, urinary uric acid clearance, and
plasma uric acidconcentration. J Am Med Assoc. 1991;266:3008–11.
13. Choi HK, De Vera MA & Krisnan E. Gout and the risk of type 2 diabetes among
men with a high cardiovascular risk profile. Rheumatology. 2008;47:1567-70.
14. Kaur A, Kukreja S, Malhotra N & Neha. Serum adenosine deaminase activity
and its correlation with glycated haemoglobin levels in patients of type 2
diabetes mellitus. Journal of Clinical and Diagnostic Research. 2012;6(2):2526.
15. Gill A, Kukreja S, Malhotra N & Chhabra N. Correlation of the serum insulin
and the serum uric acid levels with the glycated haemoglobin levels in the
patients of type 2 diabetes mellitus. Journal of Clinical and Diagnostic
Research. 2013;7(7):1295-7.
16. Markkola HV & Jarvinen HY. Hyperuricemia and insulin resistance. J Clin
Endicrinol Metab.1994;78:25-29.
17. Meera KS, Vasudha KC & Sushmitha J. The study of serum uric acid levels in
non dependent diabetes meliitus (NIDDM). Asian J Pharm Biol Res.
2011;1(3):260-6.
18. Choi HK, Ford ES. Haemoglobin A1c, fasting glucose, serum C-peptide and
insulin resistance in relation to serum uric acid levels--the Third National Health
and Nutrition Examination Survey. Rheumatology (Oxford).2008; 47:713–7.
19. Rodriguez LAG, Soriano LC, Bpharm & Choi HK. Impact of diabetes against
the future risk of developing gout. Ann Rheum Dis. 2010;69(12):2090-4.
20. Cook DG, Shaper AG, Thelle DS, Whitehead TP. Serum uric acid, serum
glucose and diabetes:relationships in a population study. Postgrad Med J . 1986;
62:1001–6.
21. Safi AJ, Mehmood R, Khan MA & Haq AU. Association of serum uric acid with
type 2 diabetes mellitus. Journal of Post Graduate Medical Institute.
2004;18(1):59-63.
22. Nan H, Pang Z, Wang S, Gao W, Zhang L, Ren J, et al. Serum uric acid, plasma
glucose and diabetes. Diabetes & Vasc Dis Res. 2010;7(1):40-6.
Universitas Sumatera Utara
35
23. Lehto S, Niskanen L, Ronnemaa T & Laakso M. Serum uric acid is a strong
predictor of stroke in patients with non-insulin-dependent diabetes mellitus.
Stroke.1998;29:635-9.
24. Heinemann L & Richter B. Clinical Pharmacology of Human Insulin. Diabetes
Care. 1993;16(3):90-100.
25. Berry CE & JM Hare. Xanthine Oxidoreductase and Cardiovascular Disease:
Molecular
Mechanism
and
Pathophysiological
Implications.
Am
JPhysiol.2004;2:589-606.
26. Dincer HE, Dincer AP, Levinson DJ. Asymptomatic Hyperuricemia: ToTreat or
Not To Treat. Cleveland Clinic Journal of Medicine. 2002;3:594-606.
27. Zhao Y, Yang X, Lu W, Liao H & Liao F. Uricase Based Methods for in
Determination of Uric Acid in Serum.Microcim Acta. 2009;164:1-6.
28. Hediger MA, Johnson RJ, Miyazaki H & Endou H. Molecular Physiology of
Urate Transport. Am J Physiol. 2005:12:125-33.
29. Heinig M and RJ Johnson. Role of Uric Acid in Hypertension, RenalDisease,
and Metabolic Syndrome. Cleveland Clinic Journal of Medicine. 2006:11:105964.
30. Wang J, Chen RP, Lei L, Song QQ, Zhang RY, Li YB, et al. Prevalence and
determinants of hyperuricemia in type 2 diabetes mellitus patients with central
obesity in Guangdong Province in China. Asia Pac J Clin Nutr. 2013;22(4):5908.
31. Putra TR. Hiperurisemia. In: Sudoyo dkk (ed). Buku Ajar IlmuPeyakit Dalam
Jilid III Edisi V. Jakarta: FKUI, pp: 2550-5.
32. Cirillo P, Sato W, Reungjui S, Heinig M, Gersch M, Sautin Y, et al. Uric Acid,
the metabolic syndrome and renal disease. J Am Soc Nephrol. 2006;17:165-8.
33. Cohen E, Krause I, Fraser A, Goldberg E & Garty M. Hyperuricemia and
metabolic
syndrome:
Lesson
from
a
large
cohort
from
Israel.
IMAJ.2012;14:676-80.
34. Dehghan A, Hoek MV, Sijbrands EJG, Hofman A & Witteman JCM. High seum
uric acid as a novel risk factor for type 2 diabetes. Diabetes Care.
2008;31(2):361-2.
Universitas Sumatera Utara
36
35. Johnson RJ, Kang DH, Feig DI, Kivlighn S, Kanelis J, Watanabe S, et al. Is
There a Pathogenic Rule of Uric Acid in Hypertension, Cardiovascular and
Renal Disease? Hypertension Journal. 2003:22(3):1183-90.
36. Stefan AD, Wolfram D, Mathias R, Rakesh S, Francis F, Christoph K, et al. Uric
Acid and Survival in Chronic Heart Failure: Validation and Application in
Metabolic, Functional, and Hemodynamic Staging. Circulation.2003;107:19917.
37. Zanardo RC, Cruz JW, Martinez LL, de Oliveira MA, Fortes ZB. Probucol
restores the defective leukocyte-endothelial interaction in experimental diabetes .
Eur J Pharmacol. 2003;478:211–9.
38. Sannomiya P, Pereira MA, Garcia-Leme J. Inhibition of leukocyte chemotaxis
by serum factor in diabetes mellitus: selective depression of cell responses
mediated by complement-derived chemoattractants. Agents Actions. 1990;
30:369–76.
39. Niskanen L, Laaksonen DE, Lindstrom J, Eriksson JG, Keinanen-Kiukaanniemi
S, Ilanne-Parikka P, et al. Serum uric acid as a harbinger of metabolic outcome
in subjects with impaired glucose tolerance: the Finnish Diabetes Prevention
Study. Diabetes Care. 2006;29:709–11.
40. Kodama S, Saito K, Yachi Y, Asumi M, Sugawara A, et al. Association between
serum uric acid and development of type 2 diabetes. Diabetes Care. 2009;32:
1737–42.
41. So A, Thorens B. Uric acid transport and disease. J Clin Invest.
2010;120(6):1791–9.
42. DeFronzo RA, Cooke CR, Andres R, et al. The effect of insulin on renal
handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest.
1975;55(4):845–55.
43. Ter Maaten JC, Voorburg A, Heine RJ, et al. Renal handling of urate and
sodium during acute physiological hyperinsulinaemia in healthy subjects. Clin
Sci (Lond). 1997;92(1):51–8.
44. Tang L, Kubota M, Nagai A, Mamemoto K, Tokuda M. Hyperuricemia in obese
children and adolescents: the relationship with metabolic syndrome. Japan
Pediatric Reports. 2010;11(2):e12-16.
Universitas Sumatera Utara
37
45. Li-ying C, Wen-hua Z, Zhou-wen C, Hong-lei D, Jing-jing R, Jian-hua C, et al.
Relationship between hyperuricemia and metabolic syndrome. Zhejiang Univ
Sci B. 2007;8(8):593-8.
46. Lia C, Hsiehb M C, Changc S J. Metabolic syndrome, diabetes, and
hyperuricemia. Curr Opin Rheumatol. 2013;25:210–6.
47. Chen J H, Pan W H, Hsu C C, Yeh W T, Chuang S Y, Chen P Y, et al. Impact of
Obesity and Hypertriglyceridemia on Gout Development With or Without
Hyperuricemia: A Prospective Study. Arthritis Care Res. 2013;65(1):133–40.
48. Carlioglu A, Karakurt F, Maral S, Kasapoglu B, Darcin T. Serum Uric Acid
Levels in Obese Women. The New Journal of Medicine. 2011;28:34-7.
49. Kim S Y, Guevara J P, Kim K M, Choi H K, Heitjan D F, Albert D A.
Hyperuricemia and Coronary Heart Disease: A Systematic Review and MetaAnalysis. Arthritis Care Res. 2010;62(2):170–80.
50. Ito H, Abe M, Mifune M, Oshikiri K, Antoku S, Takeuchi Y, et al.
Hyperuricemia Is Independently Associated with Coronary Heart Disease and
Renal Dysfunction in patients with Type 2 Diabetes MellitusTogane. Plos One.
2011;6(11):e27817-24.
51. Perticone F, Sciacqua A, Perticone M, Arturi P, Scarpino P E, Quero M, et al.
Serum Uric Acid and 1-h Postload Glucose in Essential Hypertension. Diabetes
Care.2012;35:153–7.
52. Yılmaz M B, Erdem A, Yontar O C, Sarıkaya S, Yılmaz A, Madak N, et al.
Relationship between HbA1c and coronary flow rate in patients with type 2
diabetes mellitus and angiographically normal coronary arteries. Arch Turk Soc
Cardiol. 2010;38(6):405-10.
53. Puddu P, Puddu G M, Cravero E, Vizioli L, Muscari A. The relationships among
hyperuricemia, endothelial dysfunction, and cardiovascular diseases: Molecular
mechanisms and clinical implications. J of Cardiol. 2012;59:235-42.
54. Baldwin W, McRae S, Marek G, Wymer D, Pannu V, Baylis C, et al.
Hyperuricemia as a Mediator of the Proinflammatory Endocrine Imbalance in
the Adipose Tissue in a Murine Model of the Metabolic Syndrome. Diabetes.
2011;60:1258–69.
Universitas Sumatera Utara
38
55. Jellinger P S, Smith D A, Mehta A E, Ganda O, Handelsman Y, Rodbard H W,
et al. American association of clinical endocrinologists guidelines for
management of dyslipidemia and prevention of atherosclerosis. Endocrine
Practice. 2012;18(1):1-78.
Universitas Sumatera Utara